Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release

Published:2015-04 Issue:2 Volume:25 Page:370-376
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Xin-xin,Yu Dan-dan,Chen Mao-jian,Sun Ting,Li Gang,Huang Wen-jian,Nie Hao,Wang Chao,Zhang Yan-xiang,Gong Quan,Ren Bo-xu

Funder

National Natural Science

Hubei Provincial Department of Education

Health Department of Hubei Province

College Student Innovation Experiment Program of Yangtze University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. The acute respiratory distress syndrome;Ware;N Engl J Med,2000

2. Acute respiratory distress syndrome and acute lung injury;Dushianthan;Postgrad Med J,2011

3. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury;Minamino;J Clin Invest,2006

4. Incidence and outcomes of acute lung injury;Rubenfeld;N Engl J Med,2005

5. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine;Chen;Expert Rev Respir Med,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventive effects of hesperidin in an experimental model ofs acute lung inflammation;Respiratory Physiology & Neurobiology;2024-05

2. Formation of Hesperetin-Methylglyoxal Adducts in Food and In Vivo, and Their Metabolism In Vivo and Potential Health Impacts;Journal of Agricultural and Food Chemistry;2024-04-30

3. Recent understanding of the mechanisms of the biological activities of hesperidin and hesperetin and their therapeutic effects on diseases;Heliyon;2024-03

4. Fuzhengjiedu formula exerts protective effect against LPS-induced acute lung injury via gut-lung axis;Phytomedicine;2024-01

5. Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies;Exploration of Drug Science;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3